FDA.reportPublic FDA data

opicapone 50 MG Oral Capsule [Ongentys]

RxCUI
2362182
RxNorm name
opicapone 50 MG Oral Capsule [Ongentys]
Display name
opicapone 50 MG Oral Capsule [Ongentys]
Full name
opicapone 50 MG Oral Capsule [Ongentys]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:12

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
a511a531-112e-43f8-a43f-5334b0efe979Ongentys 50 MG Oral Capsule [PSN] · opicapone 50 MG Oral Capsule [Ongentys] [SBD] · Ongentys 50 MG Oral Capsule [SY]39These highlights do not include all the information needed to use ONGENTYS ® safely and effectively. See full prescribing information for ONGENTYS ® . ONGENTYS ( opicapone ) capsules, for oral use Initial U.S. Approval: 20 2020251015